To determine if the development of the somatotropic axis in somatic clones (clones) is similar to that in heifers produced by artificial insemination (controls), serum samples were collected every 30 min for 6 h, once per month, for 7 mo from 4 clones generated from a 13-yr-old cow and from 4 age-matched controls. Average concentrations of growth hormone (GH) were not different between clones and controls, and GH concentrations declined over time in controls. Average concentrations of insulin-like growth factor I (IGF-I) were less in clones than controls, and IGF-I concentrations increased over time in both groups. Concentrations of IGF-binding protein 3 (IGFBP-3) were greater in controls than in clones and did not change over time. Average IGFBP-2 concentrations did not change over time and were not different between clones and controls. Clones and controls were challenged with GH-releasing hormone (GHRH) (3 g/100 kg body weight) and somatostatin (somatotropin release-inhibiting factor [SRIF]) (1.87 and 5 g/100 kg body weight) at 14 mo of age. GHRH-induced GH secretion was greater and SRIF inhibition of GHRH-induced GH was less in clones than in controls. We speculate that some of the differences between clones and controls in concentrations of GH, IGF-I, and IGFBP-3 may be related to the genetic merit of the animals. Although there were differences in concentrations of components of the somatotropic axis between these clones and their age-matched controls, the values recorded were all within the range reported for calves of similar ages.
INTRODUCTION
The success of cloning a whole animal from a differentiated adult cell by somatic cell nuclear transfer [1] has been reported in mice [2] [3] [4] [5] , cattle [6] [7] [8] [9] [10] [11] [12] , pigs [13] , goats [14] , and gaur [15] . The somatic cloning technology not only can be used to produce multiple copies of genetically elite animals or to regenerate tissue or organs for therapeutic cloning in biomedicine, but it is also an essential tool for basic research such as research on gene function and regulation of development. However, many developmental problems have been associated with nuclear transfer somatic cell clones. These problems include larger-than-normal calves and internal organs, high rates of fetal and postnatal mortality [16, 17] , and abnormal immune function [18] . Furthermore, cloned animals have been reported to 1 This work was supported, in part, by the University of Connecticut Research Foundation. have shorter or longer telomeres than noncloned animals [4, [19] [20] [21] . All of these observations have raised the question of whether calves cloned using adult donor cells will develop normally as young calves.
Growth hormone (GH) is a metabolic hormone associated with growth rate, accretion of protein, metabolism of adipose tissue, and milk production in cattle and pigs [22] . The secretion of GH from somatotropes in the anterior pituitary gland is a central part of the somatotropic axis, which also includes the hypothalamus, the liver, and other target tissues [22] . Two hypothalamic peptides, GH-releasing hormone (GHRH) and somatostatin (somatotropin release-inhibiting factor [SRIF]) primarily regulate secretion of GH. GHRH, a 44-amino acid peptide, stimulates release of GH, whereas SRIF inhibits GHRH-induced GH secretion [23] . In cattle, the 28-amino acid form of SRIF, as opposed to the 14-amino acid form, is responsible for this inhibitory activity in vivo [24] . GH interacts with membrane receptors, particularly in the liver, but also in other target tissues, and stimulates the production of insulin-like growth factor I (IGF-I) [25] . IGF-I functions in endocrine, paracrine, and autocrine manners and mediates many of the effects of GH [26] . IGF-I acts through its own receptor to influence the growth and differentiation of numerous cell types. Six distinct IGF-binding proteins (IGFBPs) have also been described, which bind IGF with an affinity at least equal to those of the IGF receptors [26] . IGFBP-3 is the most abundant IGFBP and is responsible for transporting IGF-I in the blood. In addition, IGFBP-2 and IGFBP-3 are responsive to exogenous GH administration in cattle [27] and pigs [28] . Importantly, age-related changes in measures of the somatotropic axis have been reported in cattle [29] and pigs [28, 30] . Although there is quite extensive animal to animal variation, in general, as animals age, average serum concentrations of GH and serum IGFBP-2 decrease [29, 31] , whereas serum concentrations of IGF-I and IGFBP-3 increase [28] [29] [30] . In Hereford calves studied from birth to 9 mo of age, we have reported a decrease in serum concentrations of GH and an increase in concentrations of IGF-I and IGFBP-3 [32] .
To date, there have been no systematic studies on the normalcy of somatic clones, other than the length of telomeres, in terms of their development. Therefore, our objective was to determine if somatic clones develop similarly to age-and weight-matched calves. Given the age-related changes in the somatotropic axis, we compared concentrations of GH, IGF-I, IGFBP-2 and IGFBP-3, and concentrations of GH after GHRH and SRIF administration in 4 cloned heifers (clones) [12, 17, 33] with those of four ageand weight-matched heifers produced by artificial insemination (AI) (controls).
MATERIALS AND METHODS

Animals
Four genetically identical cloned female calves, produced from a 13-yr-old Holstein cow of high milk production as previously described by FIG. 1. Average growth hormone concentrations in clones, controls, and postpubertal (Postpubertal) animals. The pooled SEMs for 5-11 and 14 mo of age were 3.02 and 3.63 ng/ml for clones and controls, respectively. The pooled SEM for 11 and 12 mo of age was 1.48 ng/ml for Postpubertal animals.
Tian et al. [12] , were used for this study. Of the 10 clones born alive, 4 survived (6 died within 24 h of birth). Therefore, we used the entire population of clones alive 24 h postpartum. In addition, an age-and weightmatched control Holstein calf (born within 14 days of its respective clone) for each of the 4 clones was also used in this study. All animals in clone and control groups were prepubertal at the start of the experiment (5-6 mo of age). To compare measures of the somatotropic axis in older animals at the beginning of the experiment, blood samples were also collected from postpubertal female Holstein calves (Postpubertal; n ϭ 4; 11 mo of age) and the somatic cell donor cow (Aspen; 13 yr of age). The animal use protocol for this experiment was approved by the Institutional Animal Care and Use Committee at the University of Connecticut.
Sample Collection
Once per month for 7 consecutive months (5-11 mo of age), blood samples were collected from clones and controls via jugular catheters. Samples were collected from Postpubertal heifers and Aspen in the first 2 mo. On the morning of sample collection, animals were fitted with an indwelling cannula (Abbocath-T, 16-gauge ϫ 140 mm; Abbott Laboratories, North Chicago, IL) in a jugular vein. Blood samples (10 ml) were collected every 30 min for 6 h (13 samples collected from each animal). Samples were stored at room temperature for 2-4 h and then stored overnight at 4ЊC. Serum was harvested from the cooled samples by centrifugation at 1800 ϫ g (Sorval RT7; Kendro Laboratory Products, Newtown, CT) for 30 min and stored at Ϫ20ЊC until assayed.
GHRH and SRIF Challenge
GHRH (1-44 amino acids, G-0644; Sigma Chemical Company, St. Louis, MO) and SRIF (1-28 amino acids, S-6135; Sigma) were dissolved in sterile saline (0.9%) to concentrations of 10 and 5 g/ml, respectively. At 14 mo of age, clones and controls were challenged with a bolus intravenous infusion of GHRH (3 g/100 kg body weight [BW]) on 2 consecutive days at 0900 and 1200 h. Blood samples were collected at Ϫ60, Ϫ40, Ϫ20, 0, 5, 10, 15, 20, 25, 30, 40, 50, 60, 90, and 120 min relative to each administration of GHRH. In addition, animals were infused with SRIF (1.87 or 5 g/100 kg BW) 2 min before the second GHRH administration (1158 h) on each day. To avoid confounding the effect of day with dosage, 2 animals in each group received the 1.87 g SRIF dosage and 2 received the 5.0 g SRIF dosage on the first day, and the alternate dosage was administered on the second day. Blood samples (10 ml) were collected and handled as described previously.
Serum Analysis
Serum GH was quantified in all serum samples [34] . Antisera to GH (National Institute of Diabetes and Digestive and Kidney Diseases antioGH2; AFP-C0123080 antibody, kindly provided by A.F. Parlow, National Hormone and Pituitary Program, Harbor-UCLA Medical Center, Torrance, CA) was used at a dilution of 1:20 000. Intraassay and interassay coefficients of variation for two serum pools (10.6 and 56.7 ng/ml) averaged 5.6% and 11.2%, respectively. We chose to quantify concentrations of IGF-I and not IGF-II because it has been reported that IGF-I is responsive to serum concentrations of GH [35] . Concentrations of IGFBP-3 were quantified because approximately 75% of circulating IGF-I is bound to the 150-kDa complex with IGFBP-3 and an acid-labile subunit (ALS) [26, 36] . We quantified concentrations of IGFBP-2 because they have been reported to be age-dependent and are often inversely related to concentrations of IGF-I [36, 37] . Concentrations of IGF-I were determined in two serum samples at each collection time from 5 to 11 mo and at 14 mo of age [38, 39] . All samples were quantified in a single assay with an interassay coefficient of variation of 4.8% (445 ng/ml) and 10.8% (200 ng/ml) for standard pools. Serum levels of IGFBP-2 and IGFBP-3 were determined using a Western ligand blot [40] . The data are expressed as arbitrary units and were calculated as a percentage of the signal of a standard IGFBP-3.
Data Analysis
Hormone data from serum samples (GH, IGF-I, and IGFBP-2 and IGFBP-3) collected from 5 to 11 mo of age and pre-GHRH infusion baseline samples (14 mo of age, samples 1-3) were analyzed using the Proc Mixed Model of Statistical Analysis Systems (SAS, version 8; SAS Institute, Inc., Cary, NC) [41] with repeated measures. GH data from GHRH and SRIF challenges were analyzed using the general linear model (GLM) procedure of SAS [41] . The model statement accounted for variation due to animal, sample, and dosage. Variance associated with animal by dosage was used to test for differences among dosages. Residual error was used to test for differences among samples. In addition, area under the response curve (AUC) was calculated, and areas were compared using the GLM procedures of SAS [41] . The model statement accounted for variation due to animal, period, dosage, and all interactions. Residual error (animal by period by dosage) was used to test for differences among period by dosage interactions. Data are reported as the mean Ϯ the standard error of the mean (SEM).
RESULTS
Growth Hormone
Serum concentrations of GH are shown in Figure 1 . Averaged across all time points, GH concentrations were not significantly different between clones (7.29 Ϯ 0.96 ng/ml) and controls (5.50 Ϯ 0.89 ng/ml). However, in controls, serum concentrations of GH decreased between 5 and 14 mo of age, but concentrations did not change in clones during the same time frame. Specifically, GH concentrations were greater in clones than in controls at 9, 10, and 11 mo of age, resulting in a treatment by time interaction (P Ͻ 0.01). As expected, GH concentrations in Postpubertal animals were less than those in prepubertal calves. Concentrations of GH in Postpubertal animals were less than those in controls at 5 mo of age and less than those in clones at 6 mo of age. However, when compared at similar ages (samples collected at 11 mo of age in clones and controls and at 12 mo of age in Postpubertal animals), GH concentrations were not different between Postpubertal animals and clones or controls. There were frequent pulses of GH in these clones and controls as would be expected in younger animals; however, the number of frequent pulses was not different between the two groups (Fig. 2) . The pulsatile nature of GH secretion among animals contributed to the variation around average concentrations of GH within the clone and control groups.
GHRH and SRIF Challenges
To further investigate the difference in GH concentrations at 9, 10, and 11 mo of age between clones and controls, we conducted GHRH and SRIF challenges. Based on previous reports that the GH response to GHRH varies with genetic merit in cattle [42, 43] regardless of baseline concentrations of GH, we postulated that the greater concen- trations of GH in clones were due to a greater responsiveness to GHRH and/or a reduced responsiveness to SRIF. Relative to pre-GHRH administration, GHRH induced a 15-and 10-fold increase of GH release in clones and controls, respectively, as early as 5 min after GHRH administration (P Ͻ 0.01). This increase in GH release lasted approximately 20 min, and by 40-50 min after GHRH infusion, GH returned to basal levels (Fig. 3) . Whereas the 5-g SRIF dosage completely inhibited the GHRH-induced increase of GH in both groups (data not shown), the level of inhibition of GHRH-induced GH secretion with the 1.87-g SRIF dosage was less in clones than in controls (2-and 1-fold increases of GH release, respectively; P Ͻ 0.01; Fig.  4 ).
Insulin-Like Growth Factor I
Overall, serum concentrations of IGF-I in clones and controls were parallel and increased over time from 5 to 14 mo of age. Changes in IGF-I concentrations in clone and control animals followed the same pattern, such that con- centrations of IGF-I increased from 5 to 7 mo of age and exhibited a plateau from 7 to 11 mo of age (Fig. 5) . Averaged across all time points, serum concentrations of IGF-I were less in clones than in controls (203.7 Ϯ 13.8 vs. 306.4 Ϯ 13.1 ng/ml; P Ͻ 0.001) from 5 to 11 and 14 mo of age (Fig. 5) .
IGF-Binding Proteins
Serum concentrations of IGFBP-3 paralleled IGF-I, such that, averaged across all time points, the IGFBP-3 concentration was less (P Ͻ 0.05) in clones than controls (Fig. 6) . Concentrations of IGFBP-3 did not change over time in clones or controls. The average IGFBP-2 concentration did not change over time and was not different between clones and controls (Fig. 7) .
For comparison purposes, the somatotropic axis was also monitored in the somatic cell donor of the clones. Data for the donor cow (Aspen) for the ages of 13 yr, 13 yr 1 mo, and 13 yr 10 mo, respectively, were GH (2.7, 10.0, and 6.0 ng/ml), IGF-I (152.4, 140.5, and 117.2 ng/ml), IGFBP-3 (50.4%, 51.9%, and 51.1%), and IGFBP-2 (35.4%, 43.1%, and 52.7%).
DISCUSSION
Somatic cloning is still a very challenging and low-efficiency technology. Since the birth of Dolly, the first cloned animal from an adult cell, only a handful of laboratories worldwide have reported successful effort in cloning using adult somatic cells. Furthermore, nearly all successful cloning efforts have been associated with low numbers of live births. This is mainly due to the fact that many cloned fetuses die during pregnancy and after birth. In our experience, up to 60% of somatic clones die within 24 h of birth [17] . Despite this high mortality rate, these clones used in this study were among the largest number of live clones reported at the time of their birth [6, 7, 11, 12] . Although the number is relatively low, this is by far one of the largest herds of clones from a single donor. They were born within a month of each other and represent identical copies of a potentially genetically superior cow from our research farm. Although there have been reports that telomere lengths are longer or shorter in clones [19] , telomere length did not differ between the clones and controls in the present study [12] .
Serum concentrations of GH (2-25 ng/ml), IGF-I (165-310 ng/ml), IGFBP-3 (60%-150%), and IGFBP-2 (65%-160%) in clone and control animals were in the range of data, in cattle of a similar age, previously reported by our laboratory [32, 44, 45] . Average GH concentrations during the entire experimental period were not different between clones and controls. Concentrations of GH in Postpubertal animals were less than those in clones and controls before puberty, and when Postpubertal animals were of a similar age to clones and controls (11-12 mo of age), concentrations of GH were not different. This is in agreement with previous reports that older animals have lower concentrations of GH when compared with younger animals [31] . Collectively, in terms of serum concentrations of GH, these clones exhibit developmental patterns appropriate for their age.
In this study, we observed that concentrations of GH in clones were greater than those in the controls at 9, 10, and 11 mo of age. To explain the difference between concentrations of GH in clones and controls at these ages, GHRH and SRIF, 2 hypothalamic factors that influence GH release, were administered. The magnitude of GHRH-induced GH release was greater in clones than in controls, whereas there was a greater inhibition of GHRH-induced GH release by SRIF in controls than in these clones. Lovendahl et al. [46] reported that genetic differences in cattle may be identified by GHRH stimulation of GH. Kazmer et al. [34] and Zinn et al. [42] reported that GH concentrations are greater in genetically superior bulls after GHRH administration. It has also been reported that cows that produce more milk have increased concentrations of GH compared with low-milkproducing cows [47] . Taken together, these results indicate that these clones are more responsive to GHRH and less responsive to SRIF than controls. There is no true estimate of the genetic merit of these clones, but they are all from the same genetic pool and cloned from a cow with high milk production. Although we do not have direct evidence, we speculate that the differences in concentrations of GH over time in clones may indicate that these clones are potentially of a superior genetic merit relative to controls.
Serum concentrations of IGF-I increased over time in clones and controls as previously reported in cattle [29, 31] and pigs [28] . However, averaged across all time points, IGF-I concentrations were greater in controls than in clones. Conner et al. [43] reported that bulls with greater plasma concentrations of IGF-I at a young age (at weaning) had slower rates of gain at 140 days postweaning than did bulls of a similar age with lower plasma concentrations of IGF-I at weaning. However, calves with lower plasma concentrations of IGF-I may have greater muscle and bone growth [43] . Therefore, lower concentrations of IGF-I in these clones may provide further evidence of the genetic superiority of these clones that may be expressed at an older age. Importantly, in terms of developmental change over time, patterns of IGF-I in serum were parallel between clones and controls.
IGFBPs are responsible for transporting IGF in the blood and extending the half-life of IGF-I when bound to IGF-I and an ALS, forming a ternary complex (150 kDa [37] ). Therefore, it is expected that when concentrations of IGF-I are increased, there will be a concomitant increase in serum concentrations of IGFBP-3 [28, 48] . In the current study, the concentration of IGFBP-3 was significantly greater in controls than in clones, which paralleled the increased concentrations of IGF-I. There was no change over time in IGFBP-3 concentrations in clones and controls. In contrast, previous reports in newborn calves [29] , newborn pigs [28] , and growing beef calves [32] indicate that serum IGFBP-3 concentrations increase with age. The difference between this study and those of others in concentrations of IGFBP-3 could be due to the small number of animals in this study. Average concentrations of IGFBP-2 were not different between clones and controls, and IGFBP-2 concentrations did not change over time. Similarly, Harrell et al. [28] reported that IGFBP-2 was not affected by age in growing pigs. In contrast, Skaar et al. [29] reported a decrease in IGFBP-2 concentrations in calves between 12 and 45 wk of age. Overall, clones and controls were developmentally similar over time, with no change in IGFBP-3 and IGFBP-2 concentrations noted for either group.
Summary
The developmental patterns of somatic clones, in terms of the somatotropic axis, are similar to those of agematched animals produced by AI reproduction. The variations in concentrations of GH, IGF-I, and IGFBP-3 may be a result of a difference in genetic merit, since these clones were produced from somatic cells from a single animal of high milk production and potentially superior genetic merit. The interesting finding that these clones respond differently to GHRH and SRIF may indicate that multiple clones from different genetic backgrounds are good research models for studying the effects of hormone and drug treatments by eliminating the variation of genetic influence. However, further studies are required using clones derived from different donor animals to validate this conclusion.
